Studies in Islamic Ethics is a double-blind peer-reviewed book series that covers all aspects of ethics in the Islamic world, both historical and contemporary. The series welcomes volumes in English, French, and Arabic.
The series has published three books:
Islamic Ethics and the Trusteeship Paradigm explores the emerging ethical theory of the trusteeship paradigm as developed by the Moroccan philosopher Taha Abderrahmane (b. 1944). The volume, with contributions in English and Arabic, examines the development of this modern Islamic theory of ethics and how it permeates various disciplines: philosophy, theology, legal theory, Sufism, moral theory, sociology and anthropology, communication, environment and biomedical ethics.
Islamic Ethics and the Genome Question is one of the very first academic works, which examine the field of genomics from an Islamic perspective. This twelve-chapter volume presents the results from a pioneering seminar held in 2017 at the Research Center for Islamic Legislation & Ethics, College of Islamic Studies, Hamad Bin Khalifa University, in Qatar. The contributors to this volume, coming from different disciplines and specializations, approached the key ethical questions raised by the emerging field of genomics, viz.
Migration and Islamic Ethics, Issues of Residence, Naturalization and Citizenship addresses how Islamic ethical and legal traditions can contribute to current global debates on migration and displacement; how Islamic ethics of muʾakha, ḍiyāfa, ijāra, amān, jiwār, sutra, kafāla, among others, may provide common ethical grounds for a new paradigm of social and political virtues applicable to all humanity, not only Muslims.
The power of biomedical technology lies not only in treating diseases and relieving pain, but also in intervening in our bodies at the molecular level in a way that makes us wonder if this is (re)shaping our very human nature. This technology raises ethical, philosophical and religious questions related to understanding and identifying our essential humanity, that which is “uniquely human” in us, and how far genetic interventions in our human bodies may affect all this.
When the Human Genome Project (HGP) took off in 1990, experts in the field were aware of the fact that this scientific megaproject would generate ethical questions and conundrums that should be taken seriously.2 So, an ethical arm for the HGP was established, namely the Ethical, Legal and Social Implications (ELSI) program. Five percent of the total HGP budget was dedicated to the ELSI program, making the project one of the largest-ever investments in bioethics research.
By the beginning of the twentieth century, it became clear that the ramifications of the breathtaking biomedical advancements and associated technologies will not remain within the confines of scientific and clinical practices. The complex questions and challenges raised by these advancements and technologies also necessitated profound ethical considerations.